Author:
Hartung Daniel M.,Middleton Luke,Markwardt Sheila,Williamson Kaylee,Ketchum Kathy
Funder
Oregon Comparative Effectiveness Research K12 Program
Subject
Pharmacology (medical),Pharmacology
Reference37 articles.
1. Black clouds and black boxes: comment on “Long-acting beta2-agonist step-off in patients with controlled asthma”;Chan;Arch Intern Med,2012
2. The “black box” warning and allergy drugs;Aaronson;Allergy Clin Immunol,2006
3. Serevent Nationwide Surveillance Study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment;Castle;BMJ,1993
4. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol;Nelson;Chest,2006
5. Briefing Information for the March 10-11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee. US Food and Drug Administration. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM202698.pdf (Accessed November 17, 2014).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献